Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2018; 17: 76-83
Опыт применения гетерополисахаридовс целью восстановления барьерной функции кожи у пациентов с хронической реакцией «трансплантат против хозяина»
https://doi.org/10.24287/1726-1708-2018-17-2-76-83Аннотация
Список литературы
1. Румянцев А.Г., Масчан А.А. Транс-плантация гемопоэтических стволовых клеток у детей. Руководство для врачей. - М.: ММИА, 2003.
2. Čeović R., Desnica L., Pulanić D., et al. High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease: Croatian Medical Journal 2016; 57 (3): 229-38.
3. Lee S.J. Classification systems for chronic graft-versus-host disease. Blood 2017; 129 (1): 30-7.
4. Peyraga G., Lizee T., Gustin P., Clement-Colmou K., Di Bartolo C., Supiot S., et al. Treatment of cutaneous and/or soft tissue manifestations of corticosteroids refractory chronic graft versus host disease (cGVHD) by a total nodal irradiation (TNI). Clin Transplant 2017; 31 (4): e12923.
5. Flowers M.E.D., Martin P.J. How We Treat Chronic Graft-versus-Host Disease. Blood 2015; 125 (4): 606-15.
6. Atkinson K. Clinical bone marrow and blood stem cell transplantation. Cambridge university press: 1999, 701-15, 993-1000.
7. Левашева С.В. Нарушение регуляции эпидермального барьера в формировании атопического дерматита и бронхиальной астмы у детей. Автореф. на соиск. уч. степ. канд. мед. наук. - Уфа, 2015.
8. Баррет-Хилл Фл. Косметическая химия для косметологов и дерматологов. - М.: Косметика и медицина, 2017, с. 232.
9. Hillen U., Hausermann P., Massi D., Janin A., Wolff D., Lawitschka A., Greinix H., Meyer R., Ziemer M. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease. J Eur Acad Dermatol Venereol 2015; 29 (5): 948-54.
10. Gottlöber P Leiter U, Friedrich W, Bunjes D, Schulz A, Kerscher M, Peter RU. Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography. J Eur Acad Dermatol Venereol 2003; 17 (4): 402-7.
11. Зимницкий А.Н., Башкатов С.А. Гликозаминогликаны в биохимических механизмах адаптации организма к некоторым физиологическим и патологическим состояниям. - М.: Глобус, 2004, с. 203.
12. Румянцев А.Г. Федеральные клинические рекомендации по лечению хРТПХ после трансплантации гемопоэтических стволовых клеток у детей. - НОДГО 2015: 15.
13. Гусева Н.Г. Системная склеродермия и псевдосклеродермические синдромы. - М.: Медицина, 1993: 266 с.
14. Rennie Darryn. Nailfold dermatoscopy in general practice: Aust Fam Physician, 2015; 44 (11): 809-81.
Pediatric Hematology/Oncology and Immunopathology. 2018; 17: 76-83
Usage of heteropolysaccharides to restore the skin barrier function in patients with chronic "graft versus host" disease
https://doi.org/10.24287/1726-1708-2018-17-2-76-83Abstract
The article deals with the specific features of skin changes due to the chronical «graft-versus-host disease» (GVHD) reaction and practice of its drug-free modalities. This study involved 34 patients with skin manifestations of cGVHD, that were on the standard immunosuppressive therapy or extracorporeal photopheresis. The patients received non-invasive diagnostics of skin (high frequency ultrasound of skin, photodermatoscopy, sebumetry, corneometry), and also had their skin manifestations corrected with heteropolysaccharide. The outcome of the conducted study shows that rational topographical use of heteropolysaccharide on treatment of standard immunosuppressive therapy or extracorporeal photopheresis results in the recovery of epidermal barrier, bringing relief to personal discomfort as regressing the feeling of skin tightness and pruriency, fractional reduction of rash, which is confirmed by the data of the noninvasive methods of skin treatment. The noninvasive methods of valuating multifunctional skin health (high frequency ultrasound of skin, photodermatoscopy, sebumetry, corneometry) are applicable for case follow-up of patients with skin manifestations of сGVHD.
References
1. Rumyantsev A.G., Maschan A.A. Trans-plantatsiya gemopoeticheskikh stvolovykh kletok u detei. Rukovodstvo dlya vrachei. - M.: MMIA, 2003.
2. Čeović R., Desnica L., Pulanić D., et al. High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease: Croatian Medical Journal 2016; 57 (3): 229-38.
3. Lee S.J. Classification systems for chronic graft-versus-host disease. Blood 2017; 129 (1): 30-7.
4. Peyraga G., Lizee T., Gustin P., Clement-Colmou K., Di Bartolo C., Supiot S., et al. Treatment of cutaneous and/or soft tissue manifestations of corticosteroids refractory chronic graft versus host disease (cGVHD) by a total nodal irradiation (TNI). Clin Transplant 2017; 31 (4): e12923.
5. Flowers M.E.D., Martin P.J. How We Treat Chronic Graft-versus-Host Disease. Blood 2015; 125 (4): 606-15.
6. Atkinson K. Clinical bone marrow and blood stem cell transplantation. Cambridge university press: 1999, 701-15, 993-1000.
7. Levasheva S.V. Narushenie regulyatsii epidermal'nogo bar'era v formirovanii atopicheskogo dermatita i bronkhial'noi astmy u detei. Avtoref. na soisk. uch. step. kand. med. nauk. - Ufa, 2015.
8. Barret-Khill Fl. Kosmeticheskaya khimiya dlya kosmetologov i dermatologov. - M.: Kosmetika i meditsina, 2017, s. 232.
9. Hillen U., Hausermann P., Massi D., Janin A., Wolff D., Lawitschka A., Greinix H., Meyer R., Ziemer M. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease. J Eur Acad Dermatol Venereol 2015; 29 (5): 948-54.
10. Gottlöber P Leiter U, Friedrich W, Bunjes D, Schulz A, Kerscher M, Peter RU. Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography. J Eur Acad Dermatol Venereol 2003; 17 (4): 402-7.
11. Zimnitskii A.N., Bashkatov S.A. Glikozaminoglikany v biokhimicheskikh mekhanizmakh adaptatsii organizma k nekotorym fiziologicheskim i patologicheskim sostoyaniyam. - M.: Globus, 2004, s. 203.
12. Rumyantsev A.G. Federal'nye klinicheskie rekomendatsii po lecheniyu khRTPKh posle transplantatsii gemopoeticheskikh stvolovykh kletok u detei. - NODGO 2015: 15.
13. Guseva N.G. Sistemnaya sklerodermiya i psevdosklerodermicheskie sindromy. - M.: Meditsina, 1993: 266 s.
14. Rennie Darryn. Nailfold dermatoscopy in general practice: Aust Fam Physician, 2015; 44 (11): 809-81.
